Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infants
Source
npj Vaccines - ISSN 2059-0105-11:1 (2026) p. 1-14
Identifying indicators of "success" in managing the COVID-19 pandemic in Europe : insights from an interdisciplinary expert consultation
Source
Archives of public health - ISSN 0778-7367-83:1 (2025) p. 1-12
How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countries
Source
BMJ Global Health - ISSN 2059-7908-10:8 (2025) p. 1-13
Optimizing influenza vaccine allocation by age using cost-effectiveness analysis : a comparison of 6720 vaccination program scenarios in children and adults in Belgium
Source
Epidemics - ISSN 1755-4365-51 (2025) p. 1-9
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults : a multi-country analysis
Source
BMC medicine - ISSN 1741-7015-23:1 (2025) p. 1-17